1,591
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

Retinal Vasculitis Revealing Immunoglobulin G Subclass Deficiency

, , , , , , & show all
Pages 84-86 | Received 18 Jul 2012, Accepted 24 Sep 2012, Published online: 16 Jan 2013

REFERENCES

  • Deane S, Selmi C, Naguwa SM, Teuber SS, Gershwin ME. Common variable immunodeficiency: etiological and treatment issues. Int Arch Allergy Immunol. 2009;150(4):311–324.
  • Maarschalk-Ellerbroek LJ, Hoepelman AI, van Montfrans JM, Ellerbroek PM. The spectrum of disease manifestations in patients with common variable immunodeficiency disorders and partial antibody deficiency in a university hospital. J Clin Immunol. 2012 Apr 13. DOI: 10.1007/s10875-012-9671-6 [Epub ahead of print]
  • Sleasman JW. The association between immunodeficiency and the development of autoimmune disease. Adv Dent Res. 1996 Apr;10(1):57–61.
  • Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012;119(7):1650–1657.
  • Warner JE. Vasculopathies affecting the eye. J Neuro-ophthalmol. 2004;24(2):164–169.
  • Linde A, Söderström R, Smith CI, et al. Herpesvirus serology, aberrant specific immunoglobulin G2 and G3 subclass patterns and Gm allotypes in individuals with low levels of IgG3. Clin Exp Immunol. 1992 Nov;90(2):199–203.
  • Ljungman P, Lönnqvist B, Gahrton G, Ringdén O, Sundqvist VA, Wahren B. Clinical and subclinical reactivations of varicella-zoster virus in immunocompromised patients. J Infect Dis. 1986;153(5):840–847.
  • Howe LJ, Stanford MR, Edelsten C, Graham EM. The efficacy of systemic corticosteroids in sight-threatening retinal vasculitis. Eye. 1994;8(4):443–447.
  • Abdou NI, Greenwell CA, Mehta R, Narra M, Hester JD, Halsey JF. Efficacy of intravenous gammaglobulin for immunoglobulin G subclass and/or antibody deficiency in adults. Int Arch Allergy Immunol. 2009;149(3):267–274.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.